#Efficacy

Kert Viele

KertViele

(1/n) A few weeks ago I noted that if you expecting vaccine efficacies in the 30-70% range, knowing an interim says “continue” doesn’t say much. With Pfizer’s very optimistic 90%,

Eric Feigl-Ding

DrEricDing

BREAKING—Single-shot Johnson & Johnson vaccine was 72 % effective at protecting against moderate to severe illness in US, 66 % effective in Latin America & 57 % effective in South

Jasnah Kholin - ACAB

wanderer_jasnah

so the HK vaccine advisory panel released their report re: approving it for emergency use in HK despite it not meeting data requirements & uh... it's not looking very good.here's

Ashish K. Jha, MD, MPH

ashishkjha

I've been thinking about the debate of delayed vs. immediate 2nd dose for some timeOver past week, have become convinced that getting all doses out now is betterIts NOT a

Rachel

rachelnblair

Y’all flew to Tulum, had monthly house parties, & ate inside restaurants 2x a week, risking your body having unpredictable reactions that scientific studies warned about , but you’re nervous

Shane Crotty

profshanecrotty

1/ Novavax UK first: ~90% protection again any symptomatic COVID-19. And that high level of protection was accomplished under conditions of very intense community transmission in the UK, which is

John Burn-Murdoch

jburnmurdoch

NEW: fresh data from trials in Brazil, South Africa and the UK shows the Oxford/AstraZeneca vaccine is highly effective with a 12 week gap between doses.Efficacy is in fact much

Rising serpent 🇺🇸

rising_serpent

1. The only way to end the pandemic is through, not around it.We were supposed to flatten the curve in 21 days. Fast forward 213 days and we're still talking

Bijan Salehizadeh

bijans

Spent some time today going through late-phase protocols and reported data for major COVID-vaccine programs trying to understand primary/secondary endpoint definitions. Summary: great consistency in definitions of mild/moderate/severe but..

The Meturgeman

HaMeturgeman

You can end the pandemic with 30 million doses of a vaccine by just giving it to hospital healthcare providers so they aren't too panicked by the idea of the

Prof Francois Balloux

BallouxFrancois

@mugecevik is an excellent scientist and a responsible professional. She likely read the paper more carefully than most. She grasped some of its strengths and weaknesses that are not apparent

Dr Sumaiya Shaikh

Neurophysik

COVAXIN Efficacy: A thread...n0 Q1: Is there a method to hypothesise the efficacy of COVAXIN when no data has been released?Q2: How is this efficacy enhanced & measured? Q3: Why

Psyber Attack

PsyberAttack

It's great that the UK has delivered 11M COVID vaccine doses, but let's talk about the efficacy of one dose of the Pfizer vaccine...This thread is 17 tweets long, but

Rajeev Venkayya MD

rvenkayya

THREADIn light of the Pfizer #vaccine news, a natural question is whether it's feasible to develop “better” #COVID19 vaccines after the first ones are approved?The answer is yes. It can

Brad Crane

ASP_PharmD

My 1st Thread! Some of my comments/questions re: Pfizer COVID Vaccine. ***For the record, I am a pro-vaccines***Sources: > FDA Briefing Documenthttps://www.fda.gov/media/144245/download> NEJM Article https://www.nejm.org/doi/pdf/10.10

Marcelo Moglie

mjmoglie

Really happy to see this story published as it goes back to my first steps in neuroscience as an undergraduate student. Big thanks to everyone involved, especially my co-author @irinamarcovich

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.